EBNA-2-deleted epstein-barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype epstein-barr virus from B95-8

Intervirology

Volumn 56, Issue 2, 2013, Pages 114-121

  Sano, Hitoshi ^a   Nagata, Keiko ^a   Kato, Kaoru ^a,b   Kanai, Kyousuke ^a,c   Yamamoto, Kiyoshige ^a   Okuno, Keisuke ^a   Kuwamoto, Satoshi ^a   Higaki Mori, Hiromi ^a   Sugihara, Hirotsugu ^a   Kato, Masako ^a   Murakami, Ichiro ^a   Kanzaki, Susumu ^a   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Kato Animal Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Animal model; B95 8; Epstein Barr virus; Infection; P3HR 1; Rabbit

Indexed keywords

EBER 1 PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 2; MESSENGER RNA; P3HR 1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPENDIX; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GERMINAL CENTER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MARGINAL ZONE LYMPHOMA; NONHUMAN; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL; TONSIL; VIRUS DETECTION; EXPERIMENTAL RABBIT; JAPANESE (PEOPLE); LYMPHOID TISSUE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE DELETION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; RABBITS; TIME FACTORS; VIRAL PROTEINS;

ANIMALIA; HUMAN HERPESVIRUS 4; ORYCTOLAGUS CUNICULUS;

EID: 84874387698     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000343753     Document Type: Article

References (28)

1. Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-703.
2. Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492.
3. Hant DW: Classification of Epstein-Barr associated posttransplant lymphoproliferative disease: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381-394.
4. Shope T, Dechairo D, Miller G: Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Matl Acad Sci 1973; 70: 2487-2491.
5. Epstein MA, zur Hausen H, Ball G, Rabin H: Pilot experiments with EB virus in owl monkeys ( Aotus trivirgatus ). III. Serological and biochemical findings in an animal with reticuloproliferative disease. Int J Cancer 1975; 15: 17-22.
6. Johannessen I, Crawford DH: In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol 1999; 9: 263-277.
7. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256-259.
8. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV: Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006; 12: 1316-1322.
9. Cocco M, Bellan C, Tussiwand R, Corti D, Traggiai E, Lazzi S, Mannucci S, Bronz L, Palummo N, Ginanneschi C, Tosi P, Lanzavecchia A, Manz MG, Leoncini L: CD34 + cord blood cell-transplanted Rag2-/-c-/-mice as a model for Epstein-Barr virus infection. Am J Pathol 2008; 173: 1369-1378.
10. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Honda M, Yamamoto N, Fujiwara S: A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 2008; 198: 673-682.
11. Hayashi K, Ohara N, Teramoto N, Onoda S, Chen HL, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T: An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 2001; 158: 1533-1542.
12. Hayashi K, Jin Z, Onoda S, Joko H, Teramoto N, Ohara N, Oda W, Tanaka T, Liu YX, Koirala TR, Oka T, Kondo E, Yoshino T, Takahashi K, Akagi T: Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS. Am J Pathol 2003; 162: 1721-1736.
13. Hayashi K, Joko H, Koirala TR, Onoda S, Jin ZS, Munemasa M, Ohara N, Oda W, Tanaka T, Oka T, Kondo E, Yoshino T, Takahashi K, Yamada M, Akagi T: Therapeutic trials for a rabbit model of EBV-associated hemophagocytic syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease. Histol Histopathol 2003; 18: 1155-1168.
14. Takashima K, Ohashi M, Kitamura Y, Ando K, Nagashima K, Sugihara H, Okuno K, Sairenji T, Hayashi K: A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J Med Virol 2008; 80: 455-466.
15. Okuno K, Takashima K, Kanai K, Ohashi M, Hyuga R, Sugihara H, Kuwamoto S, Kato M, Sano H, Sairenji T, Kanzaki S, Hayashi K: Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans. J Med Virol 2010; 82: 977-986.
16. Kanai K, Takashima K, Okuno K, Kato K, Sano H, Kuwamoto S, Higaki H, Nagata K, Sugihara H, Kato M, Murakami I, Hayashi K: Lifelong persistent EBV infection of rabbits with EBER-1-positive lymphocyte infiltration and mild sublethal hemophagocytosis. Virus Res 2010; 153: 172-178.
17. Jeang KT, Hayward SD: Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript. J Virol 1983; 48: 135-148.
18. Biggin M, Bodescot M, Perricaudet M, Farrell P: Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol 1987; 61: 3120-3132.
19. Rabson M, Gradoville L, Heston L, Miller G: Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol 1982; 44: 834-844.
20. Harada S, Kieff E: Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 1997; 71: 6611-6618.
21. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG: DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-211.
22. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T: Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132-136.
23. Bergallo M, Costa C, Baro S, Musso T, Balbo L, Merlino C, Cavallo R: Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression. J Biotechnol 2007; 128: 462-476.
24. Chang KL, Chen YY, Shibata D, Weiss LM: Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992; 1: 246-255.
25. Hanson NB, Lanning DK: Microbial induction of B and T cell areas in rabbit appendix. Dev Comp Immunol 2008; 32: 980-991.
26. Babcock GJ, Hochberg D, Thorley-Lawson AD: The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000; 13: 497-506.
27. Joseph AM, Babcock GJ, Thorley-Lawson DA: Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J Virol 2000; 74: 9964-9971.
28. Kurth J, Hansmann ML, Rajewsky K, Küppers R: Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci USA 2003; 100: 4730-4735.